Results 231 to 240 of about 263,787 (314)

The oncogenic role of human papillomavirus in breast cancer: a comprehensive systematic review and meta-analysis. [PDF]

Front Microbiol
Koishybayeva D, Balmagambetova S, Zhakiev B, Koishybayev A, Mussin NM, Sakhanova S, Aitmagambetova M, Tulyayeva A, Tamadon A.   +8 more
europepmc   +1 more source

CDKN2A deletion in p16‐negative/HPV‐positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement

Histopathology, EarlyView.
We present a case series of HPV‐positive non‐keratinizing squamous cell carcinoma of the head and neck with discordant negative p16 staining due to CDKN2A deletion. These findings highlight the genomic basis behind the diagnostic pitfall of reliance on p16 immunohistochemistry as a surrogate marker of HPV and raise practice‐changing considerations for ...
Trevor Teich, Rong Hu, Anita Nagy, Mary Shago, Yen Chen Kevin Ko, Carl Ren, Raja R Seethala, Bibianna Purgina, Elan Hahn   +8 more
wiley   +1 more source

Human Papillomavirus Persistence, Recurrence, and Incidence in Early Childhood. [PDF]

J Infect Dis
Bénard EA, Carceller AM, Mayrand MH, Lacroix J, Niyibizi J, Laporte L, Audibert F, Coutlée F, Trottier H, HERITAGE Study Group .   +9 more
europepmc   +1 more source

Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors

International Journal of Dermatology, EarlyView.
Inmunization and Screening Protocol for the Safe Initiation of JAK Inhibitors. ABSTRACT Atopic dermatitis therapy has undergone a revolutionary change with the introduction of Janus kinase (JAK) inhibitors. Despite their general safety profile, these immunomodulatory drugs require special precautions with respect to infection risk and vaccine ...
Mariano Ara‐Martín, Carolina Moreno, Ricardo Ruiz‐Villaverde, Esther Serra‐Baldrich, Irene Hernández‐Martín, Maria del Pilar Fortes   +5 more
wiley   +1 more source

Healthcare professionals' knowledge and attitude toward Human papillomavirus vaccination: A critical appraisal of research evidence. [PDF]

J Educ Health Promot
Roudsari RL, Rakhshkhorshid M, Jafari H.
europepmc   +1 more source

Primary and Secondary Grzybowski’s Generalized Eruptive Keratoacanthoma: A New Perspective on Management, Clinical Features, and Prognosis

International Journal of Dermatology, EarlyView.
ABSTRACT Grzybowski's generalized eruptive keratoacanthoma (GEKA) is a rare variant of keratoacanthomas, characterized by hundreds to thousands of lesions, accompanied by pruritus, mucosal involvement, and comorbidities. Our aim was to analyze the clinical presentation, associated comorbidities, treatment strategies, and outcomes of GEKA.
Nicholas Florin Kormos, Carina Maria Petrenciu, Alin Stefan Vizitiu, Raluca Ghețe, Umer Nadir, Adrian Lucian Baican, Stanislav N. Tolkachjov   +6 more
wiley   +1 more source

Prevalence characteristics of human papillomavirus among women in Henan Province of China. [PDF]

Virol J
Zhu X, Li S, Zhuang C.
europepmc   +1 more source

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Primary and Secondary Prophylaxis for Diseases Caused by Human Papillomavirus Infections. [PDF]

J Cancer Prev
Hristamyan MA.
europepmc   +1 more source

HIV: is it now a thing of the past?

Internal Medicine Journal, EarlyView.
Abstract Effective antiviral therapy for human immunodeficiency virus (HIV) has substantially reduced HIV‐associated morbidity and mortality for people living with HIV (PLWH). The use of antiviral therapies as prevention, most notably pre‐exposure prophylaxis (PrEP) as well as treatment as prevention (TasP), has significantly reduced the number of new ...
Jeffrey John Post
wiley   +1 more source